JP2014500257A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014500257A5 JP2014500257A5 JP2013539370A JP2013539370A JP2014500257A5 JP 2014500257 A5 JP2014500257 A5 JP 2014500257A5 JP 2013539370 A JP2013539370 A JP 2013539370A JP 2013539370 A JP2013539370 A JP 2013539370A JP 2014500257 A5 JP2014500257 A5 JP 2014500257A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- pharmaceutical formulation
- hyaluronic acid
- formulation according
- concentration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 22
- 239000008194 pharmaceutical composition Substances 0.000 claims 13
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims 12
- 229920002674 hyaluronan Polymers 0.000 claims 12
- 229960003160 hyaluronic acid Drugs 0.000 claims 12
- 229910052709 silver Inorganic materials 0.000 claims 10
- 239000004332 silver Substances 0.000 claims 10
- 229910052751 metal Inorganic materials 0.000 claims 9
- 239000002184 metal Substances 0.000 claims 9
- 239000003814 drug Substances 0.000 claims 5
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 claims 5
- 239000003380 propellant Substances 0.000 claims 5
- 231100000444 skin lesion Toxicity 0.000 claims 5
- 206010040882 skin lesion Diseases 0.000 claims 5
- 230000000699 topical effect Effects 0.000 claims 5
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 claims 4
- 206010072170 Skin wound Diseases 0.000 claims 4
- NNPPMTNAJDCUHE-UHFFFAOYSA-N isobutane Chemical compound CC(C)C NNPPMTNAJDCUHE-UHFFFAOYSA-N 0.000 claims 4
- 239000007921 spray Substances 0.000 claims 4
- 238000009472 formulation Methods 0.000 claims 3
- 239000006260 foam Substances 0.000 claims 2
- 239000001282 iso-butane Substances 0.000 claims 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 2
- 239000001294 propane Substances 0.000 claims 2
- 206010052428 Wound Diseases 0.000 claims 1
- 208000027418 Wounds and injury Diseases 0.000 claims 1
- 230000036576 dermal application Effects 0.000 claims 1
- 230000003902 lesion Effects 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
- 239000003981 vehicle Substances 0.000 claims 1
- 230000029663 wound healing Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITPD2010A000349 | 2010-11-19 | ||
| ITPD2010A000349A IT1402786B1 (it) | 2010-11-19 | 2010-11-19 | Composizioni farmaceutiche ad attivita' antibatterica e cicatrizzante |
| PCT/IB2011/054923 WO2012066447A1 (en) | 2010-11-19 | 2011-11-04 | Compositions with antibacterial and wound healing activity |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014500257A JP2014500257A (ja) | 2014-01-09 |
| JP2014500257A5 true JP2014500257A5 (enExample) | 2014-10-23 |
| JP6092781B2 JP6092781B2 (ja) | 2017-03-08 |
Family
ID=43742908
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013539370A Active JP6092781B2 (ja) | 2010-11-19 | 2011-11-04 | 抗菌および創傷治癒活性を持つ組成物 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US9265793B2 (enExample) |
| EP (1) | EP2640401B1 (enExample) |
| JP (1) | JP6092781B2 (enExample) |
| CN (1) | CN103249419B (enExample) |
| AU (1) | AU2011330855B2 (enExample) |
| BR (1) | BR112013012120A2 (enExample) |
| CA (1) | CA2815810C (enExample) |
| ES (1) | ES2588397T3 (enExample) |
| IL (1) | IL226220A (enExample) |
| IT (1) | IT1402786B1 (enExample) |
| MX (1) | MX2013005593A (enExample) |
| RU (1) | RU2611046C2 (enExample) |
| SI (1) | SI2640401T1 (enExample) |
| SM (1) | SMT201600381B (enExample) |
| WO (1) | WO2012066447A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2978664B1 (fr) * | 2011-08-04 | 2014-01-10 | Petcare Innovation | Composition antiseptique |
| CN103191461B (zh) * | 2013-04-26 | 2015-09-16 | 华熙福瑞达生物医药有限公司 | 一种含透明质酸的伤口护理用敷料 |
| ITMI20130883A1 (it) * | 2013-05-30 | 2014-12-01 | Eurores S R L | Composizioni farmaceutiche comprendenti collagene e sodio ialuronato |
| US20150064129A1 (en) * | 2013-09-04 | 2015-03-05 | Taiwan Biotech Co., Ltd. | Wound healing composition |
| CN116669717A (zh) * | 2020-08-17 | 2023-08-29 | 美国人福制药公司 | 长效原位成型/胶凝组合物 |
| TWI823516B (zh) * | 2022-08-10 | 2023-11-21 | 鈺永科技有限公司 | 由有機鍺化合物和葡萄糖胺化合物製備的藥物及其用途 |
| TWM680381U (zh) * | 2024-12-24 | 2026-02-21 | 聿健生物科技股份有限公司 | 敷料製造裝置及敷料產品 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1987005517A1 (en) * | 1986-03-14 | 1987-09-24 | Bio-Technology General Corp. | Heavy metal salts of hyaluronic acid useful as antimicrobial agents |
| IT1263394B (it) * | 1993-07-30 | 1996-08-05 | Fidia Advanced Biopolymers Srl | Composizioni farmaceutiche per uso topico a base di acido ialuronico e suoi derivati |
| IT1281877B1 (it) * | 1995-05-10 | 1998-03-03 | Fidia Advanced Biopolymers Srl | Sali di metalli pesanti di succinil derivati dell'acido ialuronico e loro impiego come potenziali agenti terapeutici |
| IT1317359B1 (it) * | 2000-08-31 | 2003-06-16 | Fidia Advanced Biopolymers Srl | Polisaccaridi percarbossilati, quali l'acido ialuronico, processo perla loro preparazione e loro impiego in campo farmaceutico e |
| JP2002173405A (ja) * | 2000-12-04 | 2002-06-21 | Hidehiro Tagusari | コロイド銀による殺菌方法及びこれを用いた殺菌処理材 |
| AU2003263344B2 (en) * | 2002-09-11 | 2009-01-08 | Johnson & Johnson Medical Limited | Wound dressing materials comprising complexes of anionic polysaccharides with silver |
| US7186416B2 (en) * | 2003-05-28 | 2007-03-06 | Stiefel Laboratories, Inc. | Foamable pharmaceutical compositions and methods for treating a disorder |
| DE10340277B4 (de) * | 2003-08-29 | 2006-11-23 | Bio-Gate Bioinnovative Materials Gmbh | Körperpflegemittel mit Silber-Agglomeraten |
| WO2005032417A2 (en) * | 2003-09-30 | 2005-04-14 | Synthes (Usa) | Antimicrobial hyaluronic acid coatings for orthopedic implants |
| US20050112151A1 (en) * | 2003-11-20 | 2005-05-26 | Horng Liou L. | Skin adherent hydrogels |
| CN101001649B (zh) * | 2004-07-09 | 2011-08-31 | 弗罗桑医疗设备公司 | 包括透明质酸的止血组合物及其制备方法 |
| DE102005008299B4 (de) | 2005-02-23 | 2025-07-10 | Bio-Gate Ag | Kosmetische und/oder dermatologische Formulierung, Verfahren zu deren Herstellung und Verwendung der Formulierung |
| US20100113871A1 (en) * | 2006-09-13 | 2010-05-06 | Aylvin Jorge Angelo Athanasius Dias | Antimicrobial coating |
| DE102007044582A1 (de) * | 2007-09-19 | 2009-04-09 | Deckner, Peter G., Dr. med. | Zusammensetzung für Wundbehandlungen im Humanbereich |
| DE102007044583A1 (de) * | 2007-09-19 | 2009-04-09 | Deckner, Peter G., Dr. med. | Zusammensetzung für Wundbehandlungen im Veterinärbereich |
| DE102008031023A1 (de) * | 2008-06-30 | 2009-12-31 | Neubourg Skin Care Gmbh & Co. Kg | Schaumhautpflegecreme |
| EP2218447B1 (en) | 2008-11-04 | 2017-04-19 | PharmaSol GmbH | Compositions containing lipid micro- or nanoparticles for the enhancement of the dermal action of solid particles |
| WO2010127647A1 (de) * | 2009-05-08 | 2010-11-11 | Deckner Peter G | Zusammensetzungen für wundbehandlungen im human-, und veterinärbereich |
-
2010
- 2010-11-19 IT ITPD2010A000349A patent/IT1402786B1/it active
-
2011
- 2011-11-04 EP EP11799117.4A patent/EP2640401B1/en active Active
- 2011-11-04 CA CA2815810A patent/CA2815810C/en active Active
- 2011-11-04 ES ES11799117.4T patent/ES2588397T3/es active Active
- 2011-11-04 US US13/988,285 patent/US9265793B2/en active Active
- 2011-11-04 BR BR112013012120A patent/BR112013012120A2/pt not_active IP Right Cessation
- 2011-11-04 WO PCT/IB2011/054923 patent/WO2012066447A1/en not_active Ceased
- 2011-11-04 RU RU2013127673A patent/RU2611046C2/ru active
- 2011-11-04 AU AU2011330855A patent/AU2011330855B2/en active Active
- 2011-11-04 CN CN201180055714.7A patent/CN103249419B/zh active Active
- 2011-11-04 JP JP2013539370A patent/JP6092781B2/ja active Active
- 2011-11-04 MX MX2013005593A patent/MX2013005593A/es active IP Right Grant
- 2011-11-04 SI SI201130952A patent/SI2640401T1/sl unknown
-
2013
- 2013-05-07 IL IL226220A patent/IL226220A/en active IP Right Grant
-
2016
- 2016-10-26 SM SM201600381T patent/SMT201600381B/it unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2011002755A1 (es) | Composicion farmaceutica topica que comprende particulas de fosfato de calcio nanoporosas, esfericas, donde al menos 90% o mas de las particulas tienen un diametro promedio de 2 micrometros o menos y estan enlazadas a un agente farmacologicamente activo. | |
| JP2016516808A5 (enExample) | ||
| RU2013127673A (ru) | Композиции с антибактериальной и ранозаживляющей активностью | |
| Karami et al. | Synthesis and characterization of a novel hydrogel based on carboxymethyl chitosan/sodium alginate with the ability to release simvastatin for chronic wound healing | |
| JP2009280627A5 (enExample) | ||
| JP2011521969A5 (enExample) | ||
| JP2015509788A5 (enExample) | ||
| JP2004536045A5 (enExample) | ||
| JP4838242B2 (ja) | アルギネートを含む多孔性成型品の製造方法 | |
| JP2014510590A5 (enExample) | ||
| JP2013511534A5 (enExample) | ||
| JP2016538271A5 (enExample) | ||
| JP2010254688A5 (enExample) | ||
| NZ703808A (en) | Topical transdermal dexmedetomidine compositions and methods of use thereof | |
| Fang et al. | The effectiveness of topical anti-scarring agents and a novel combined process on cutaneous scar management | |
| JP2015536939A5 (enExample) | ||
| JP2017514825A5 (enExample) | ||
| CN101641103B (zh) | 脱乙酰壳多糖在制备用于治疗指/趾甲炎症性疾病的药物中的用途 | |
| JP2016540825A5 (enExample) | ||
| CA2900982C (en) | Ultrapure tetrahydrocannabinol-11-oic acids | |
| EP3013376A1 (en) | Method of reducing scarring | |
| JP2020524689A5 (enExample) | ||
| RU2015102772A (ru) | Бензодиазелипы для мелкоклеточного рака легкого | |
| WO2012051614A3 (en) | Delivery of hydrophobic bioactive agents | |
| WO2015019304A3 (fr) | Compositions à libération continue à base d'acide hyaluronique, et leurs applications thérapeutiques |